Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice

Abstract Background Acute liver failure resulting from drug-induced liver injury can lead to the development of neurological complications called hepatic encephalopathy (HE). Hepatic transforming growth factor beta 1 (TGFβ1) is upregulated due to liver failure in mice and inhibiting circulating TGFβ...

Full description

Bibliographic Details
Main Authors: Matthew McMillin, Stephanie Grant, Gabriel Frampton, Anca D. Petrescu, Elaina Williams, Brandi Jefferson, Alison Thomas, Ankita Brahmaroutu, Sharon DeMorrow
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12974-019-1455-y
_version_ 1798043678246174720
author Matthew McMillin
Stephanie Grant
Gabriel Frampton
Anca D. Petrescu
Elaina Williams
Brandi Jefferson
Alison Thomas
Ankita Brahmaroutu
Sharon DeMorrow
author_facet Matthew McMillin
Stephanie Grant
Gabriel Frampton
Anca D. Petrescu
Elaina Williams
Brandi Jefferson
Alison Thomas
Ankita Brahmaroutu
Sharon DeMorrow
author_sort Matthew McMillin
collection DOAJ
description Abstract Background Acute liver failure resulting from drug-induced liver injury can lead to the development of neurological complications called hepatic encephalopathy (HE). Hepatic transforming growth factor beta 1 (TGFβ1) is upregulated due to liver failure in mice and inhibiting circulating TGFβ reduced HE progression. However, the specific contributions of TGFβ1 on brain cell populations and neuroinflammation during HE are not known. Therefore, the aim of this study was to characterize hepatic and brain TGFβ1 signaling during acute liver failure and its contribution to HE progression using a combination of pharmacological and genetic approaches. Methods C57Bl/6 or neuron-specific transforming growth factor beta receptor 2 (TGFβR2) null mice (TGFβR2ΔNeu) were treated with azoxymethane (AOM) to induce acute liver failure and HE. The activity of circulating TGFβ1 was inhibited in C57Bl/6 mice via injection of a neutralizing antibody against TGFβ1 (anti-TGFβ1) prior to AOM injection. In all mouse treatment groups, liver damage, neuroinflammation, and neurological deficits were assessed. Inflammatory signaling between neurons and microglia were investigated in in vitro studies through the use of pharmacological inhibitors of TGFβ1 signaling in HT-22 and EOC-20 cells. Results TGFβ1 was expressed and upregulated in the liver following AOM injection. Pharmacological inhibition of TGFβ1 after AOM injection attenuated neurological decline, microglia activation, and neuroinflammation with no significant changes in liver damage. TGFβR2ΔNeu mice administered AOM showed no effect on liver pathology but significantly reduced neurological decline compared to control mice. Microglia activation and neuroinflammation were attenuated in mice with pharmacological inhibition of TGFβ1 or in TGFβR2ΔNeu mice. TGFβ1 increased chemokine ligand 2 (CCL2) and decreased C-X3-C motif ligand 1 (CX3CL1) expression in HT-22 cells and reduced interleukin-1 beta (IL-1ß) expression, tumor necrosis factor alpha (TNFα) expression, and phagocytosis activity in EOC-20 cells. Conclusion Increased circulating TGFβ1 following acute liver failure results in activation of neuronal TGFβR2 signaling, driving neuroinflammation and neurological decline during AOM-induced HE.
first_indexed 2024-04-11T22:52:27Z
format Article
id doaj.art-1cdba4273ef84def81caad854bf28d94
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-04-11T22:52:27Z
publishDate 2019-04-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-1cdba4273ef84def81caad854bf28d942022-12-22T03:58:32ZengBMCJournal of Neuroinflammation1742-20942019-04-0116111510.1186/s12974-019-1455-yElevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in miceMatthew McMillin0Stephanie Grant1Gabriel Frampton2Anca D. Petrescu3Elaina Williams4Brandi Jefferson5Alison Thomas6Ankita Brahmaroutu7Sharon DeMorrow8Central Texas Veterans Health Care SystemCentral Texas Veterans Health Care SystemCentral Texas Veterans Health Care SystemCentral Texas Veterans Health Care SystemCentral Texas Veterans Health Care SystemCentral Texas Veterans Health Care SystemDepartment of Medical Physiology, College of Medicine, Texas A&M University Health Science CenterDepartment of Medical Physiology, College of Medicine, Texas A&M University Health Science CenterCentral Texas Veterans Health Care SystemAbstract Background Acute liver failure resulting from drug-induced liver injury can lead to the development of neurological complications called hepatic encephalopathy (HE). Hepatic transforming growth factor beta 1 (TGFβ1) is upregulated due to liver failure in mice and inhibiting circulating TGFβ reduced HE progression. However, the specific contributions of TGFβ1 on brain cell populations and neuroinflammation during HE are not known. Therefore, the aim of this study was to characterize hepatic and brain TGFβ1 signaling during acute liver failure and its contribution to HE progression using a combination of pharmacological and genetic approaches. Methods C57Bl/6 or neuron-specific transforming growth factor beta receptor 2 (TGFβR2) null mice (TGFβR2ΔNeu) were treated with azoxymethane (AOM) to induce acute liver failure and HE. The activity of circulating TGFβ1 was inhibited in C57Bl/6 mice via injection of a neutralizing antibody against TGFβ1 (anti-TGFβ1) prior to AOM injection. In all mouse treatment groups, liver damage, neuroinflammation, and neurological deficits were assessed. Inflammatory signaling between neurons and microglia were investigated in in vitro studies through the use of pharmacological inhibitors of TGFβ1 signaling in HT-22 and EOC-20 cells. Results TGFβ1 was expressed and upregulated in the liver following AOM injection. Pharmacological inhibition of TGFβ1 after AOM injection attenuated neurological decline, microglia activation, and neuroinflammation with no significant changes in liver damage. TGFβR2ΔNeu mice administered AOM showed no effect on liver pathology but significantly reduced neurological decline compared to control mice. Microglia activation and neuroinflammation were attenuated in mice with pharmacological inhibition of TGFβ1 or in TGFβR2ΔNeu mice. TGFβ1 increased chemokine ligand 2 (CCL2) and decreased C-X3-C motif ligand 1 (CX3CL1) expression in HT-22 cells and reduced interleukin-1 beta (IL-1ß) expression, tumor necrosis factor alpha (TNFα) expression, and phagocytosis activity in EOC-20 cells. Conclusion Increased circulating TGFβ1 following acute liver failure results in activation of neuronal TGFβR2 signaling, driving neuroinflammation and neurological decline during AOM-induced HE.http://link.springer.com/article/10.1186/s12974-019-1455-yAcute liver failureAzoxymethaneMicrogliaNeuroinflammationNecrosis
spellingShingle Matthew McMillin
Stephanie Grant
Gabriel Frampton
Anca D. Petrescu
Elaina Williams
Brandi Jefferson
Alison Thomas
Ankita Brahmaroutu
Sharon DeMorrow
Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice
Journal of Neuroinflammation
Acute liver failure
Azoxymethane
Microglia
Neuroinflammation
Necrosis
title Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice
title_full Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice
title_fullStr Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice
title_full_unstemmed Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice
title_short Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice
title_sort elevated circulating tgfβ1 during acute liver failure activates tgfβr2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice
topic Acute liver failure
Azoxymethane
Microglia
Neuroinflammation
Necrosis
url http://link.springer.com/article/10.1186/s12974-019-1455-y
work_keys_str_mv AT matthewmcmillin elevatedcirculatingtgfb1duringacuteliverfailureactivatestgfbr2oncorticalneuronsandexacerbatesneuroinflammationandhepaticencephalopathyinmice
AT stephaniegrant elevatedcirculatingtgfb1duringacuteliverfailureactivatestgfbr2oncorticalneuronsandexacerbatesneuroinflammationandhepaticencephalopathyinmice
AT gabrielframpton elevatedcirculatingtgfb1duringacuteliverfailureactivatestgfbr2oncorticalneuronsandexacerbatesneuroinflammationandhepaticencephalopathyinmice
AT ancadpetrescu elevatedcirculatingtgfb1duringacuteliverfailureactivatestgfbr2oncorticalneuronsandexacerbatesneuroinflammationandhepaticencephalopathyinmice
AT elainawilliams elevatedcirculatingtgfb1duringacuteliverfailureactivatestgfbr2oncorticalneuronsandexacerbatesneuroinflammationandhepaticencephalopathyinmice
AT brandijefferson elevatedcirculatingtgfb1duringacuteliverfailureactivatestgfbr2oncorticalneuronsandexacerbatesneuroinflammationandhepaticencephalopathyinmice
AT alisonthomas elevatedcirculatingtgfb1duringacuteliverfailureactivatestgfbr2oncorticalneuronsandexacerbatesneuroinflammationandhepaticencephalopathyinmice
AT ankitabrahmaroutu elevatedcirculatingtgfb1duringacuteliverfailureactivatestgfbr2oncorticalneuronsandexacerbatesneuroinflammationandhepaticencephalopathyinmice
AT sharondemorrow elevatedcirculatingtgfb1duringacuteliverfailureactivatestgfbr2oncorticalneuronsandexacerbatesneuroinflammationandhepaticencephalopathyinmice